Telomir Pharmaceuticals TELO
NASDAQ TELO
$1.17 -0.03 (-2.50%)
At close: Sep 29, 2026 · 4:00 PM EDT

Telomir Pharmaceuticals (TELO) Other financing activities (2023)

Updated

Telomir Pharmaceuticals' Other financing activities was $200,387 in Q4 2023, up 833.9% from the prior quarter.

Analysis

Telomir Pharmaceuticals (TELO) Other financing activities (2023) Analysis & Trends

For FY2023, Other financing activities at Telomir Pharmaceuticals came in at $255,970, up 441.0% from FY2022.

  • In earlier years, Other financing activities was $47,311 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Telomir Pharmaceuticals 82.53 Mn 82.53 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 200,387.00
Sep 30, 2023 21,457.00
API Access

Telomir Pharmaceuticals Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=TELO&period=max&api_key=YOUR_API_KEY